Comparative proteomic analysis of three major extracellular vesicle classes secreted from human primary and metastatic colorectal cancer cells: Exosomes, microparticles, and shed midbody remnants.

Cell-derived extracellular vesicles (EVs) are evolutionary-conserved secretory organelles that, based on their molecular composition, are important intercellular signaling regulators. At least three classes of circulating EVs are known based on mechanism of biogenesis: exosomes (sEVs/Exos), microparticles (lEVs/MPs), and shed midbody remnants (lEVs/sMB-Rs). sEVs/Exos are of endosomal pathway origin, microparticles (lEVs/MPs) from plasma membrane blebbing and shed midbody remnants (lEVs/sMB-Rs) arise from symmetric cytokinetic abscission. Here, we isolate sEVs/Exos, lEVs/MPs, and lEVs/sMB-Rs secreted from human isogenic primary (SW480) and metastatic (SW620) colorectal cancer (CRC) cell lines in milligram quantities for label-free MS/MS-based proteomic profiling. Purified EVs revealed selective composition packaging of exosomal protein markers in SW480/SW620-sEVs/Exos, metabolic enzymes in SW480/SW620-lEVs/MPs, while centralspindlin complex proteins, nucleoproteins, splicing factors, RNA granule proteins, translation-initiation factors, and mitochondrial proteins selectively traffic to SW480/SW620- lEVs/sMB-Rs. Collectively, we identify 39 human cancer-associated genes in EVs; 17 associated with SW480-EVs, 22 with SW620-EVs. We highlight oncogenic receptors/transporters selectively enriched in sEVs/Exos (EGFR/FAS in SW480-sEVs/Exos and MET, TGFBR2, ABCB1 in SW620-sEVs/Exos). Interestingly, MDK, STAT1, and TGM2 are selectively enriched in SW480-lEVs/sMB-Rs, and ADAM15 to SW620-lEVs/sMB-Rs. Our study reveals sEVs/Exos, lEVs/MPs, and lEVs/sMB-Rs have distinct protein signatures that open potential diagnostic avenues of distinct types of EVs for clinical utility.

[1]  A. Clayton,et al.  Challenges and directions in studying cell–cell communication by extracellular vesicles , 2022, Nature Reviews Molecular Cell Biology.

[2]  Jian Peng,et al.  Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible? , 2022, Biochimie.

[3]  Qiu-lin Tang,et al.  Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer , 2021, Molecular Cancer.

[4]  Xiaoyu Hu,et al.  Mitocytosis, a migrasome-mediated mitochondrial quality-control process , 2021, Cell.

[5]  U. Chandran,et al.  Microvesicles Transfer Mitochondria and Increase Mitochondrial Function in Brain Endothelial Cells , 2021, bioRxiv.

[6]  A. Hidalgo-Miranda,et al.  Quantitative proteomic analysis of extracellular vesicle subgroups isolated by an optimized method combining polymer‐based precipitation and size exclusion chromatography , 2021, Journal of extracellular vesicles.

[7]  R. Simpson,et al.  Secreted midbody remnants are a class of extracellular vesicles molecularly distinct from exosomes and microparticles , 2021, Communications biology.

[8]  M. Tremblay,et al.  Platelets release mitochondrial antigens in systemic lupus erythematosus , 2021, Science Translational Medicine.

[9]  S. Chakrabortty,et al.  Exosome-based liquid biopsies in cancer: opportunities and challenges , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  Yohan Kim,et al.  Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in Down syndrome , 2021, Science Advances.

[11]  E. Mukamel,et al.  Single-Cell Sequencing of Brain Cell Transcriptomes and Epigenomes , 2021, Neuron.

[12]  H. An,et al.  Acetylation and Deacetylation of DNA Repair Proteins in Cancers , 2020, Frontiers in Oncology.

[13]  Shu Zheng,et al.  Application of exosomes as liquid biopsy in clinical diagnosis , 2020, Signal Transduction and Targeted Therapy.

[14]  J. Yun,et al.  GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma , 2020, Theranostics.

[15]  A. Echard,et al.  The Flemmingsome reveals an ESCRT-to-membrane coupling via ALIX/syntenin/syndecan-4 required for completion of cytokinesis , 2020, Nature Communications.

[16]  G. Karagiannis,et al.  Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target , 2019, Oncogene.

[17]  R. Simpson,et al.  Proteomic profiling reveals key cancer progression modulators in shed microvesicles released from isogenic human primary and metastatic colorectal cancer cell lines. , 2019, Biochimica et biophysica acta. Proteins and proteomics.

[18]  Anton J. Enright,et al.  The midbody interactome reveals unexpected roles for PP1 phosphatases in cytokinesis , 2019, Nature Communications.

[19]  G. Raposo,et al.  The post-abscission midbody is an intracellular signaling organelle that regulates cell proliferation , 2019, Nature Communications.

[20]  Michael Zhuo Wang,et al.  Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis , 2019, Cells.

[21]  Dylan T Burnette,et al.  Reassessment of Exosome Composition , 2019, Cell.

[22]  Annie W Shieh,et al.  Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder , 2018, Science.

[23]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[24]  M. K. Pflum,et al.  HDAC1 Substrate Profiling Using Proteomics-Based Substrate Trapping. , 2018, ACS chemical biology.

[25]  R. Simpson,et al.  Understanding extracellular vesicle diversity – current status , 2018, Expert review of proteomics.

[26]  David W. Greening,et al.  Extracellular vesicles in cancer — implications for future improvements in cancer care , 2018, Nature Reviews Clinical Oncology.

[27]  Juan Xu,et al.  Synovial fluid-derived exosomal lncRNA PCGEM1 as biomarker for the different stages of osteoarthritis , 2018, International Orthopaedics.

[28]  T. Dokland,et al.  Exosomal transfer of mitochondria from airway myeloid-derived regulatory cells to T cells☆ , 2018, Redox biology.

[29]  Imre Mäger,et al.  Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression , 2018, Front. Immunol..

[30]  H. Valadi,et al.  Identification of RNA-binding proteins in exosomes capable of interacting with different types of RNA: RBP-facilitated transport of RNAs into exosomes , 2018, PloS one.

[31]  Graça Raposo,et al.  Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.

[32]  R. Parker,et al.  Isolation of yeast and mammalian stress granule cores. , 2017, Methods.

[33]  Alicia Llorente,et al.  Current knowledge on exosome biogenesis and release , 2017, Cellular and Molecular Life Sciences.

[34]  S. Jakob,et al.  Isolation of Intact Mitochondria from Skeletal Muscle by Differential Centrifugation for High-resolution Respirometry Measurements. , 2017, Journal of visualized experiments : JoVE.

[35]  A. Koromilas,et al.  STAT1 Promotes KRAS Colon Tumor Growth and Susceptibility to Pharmacological Inhibition of Translation Initiation Factor eIF4A , 2016, Molecular Cancer Therapeutics.

[36]  Hong-Jian Zhu,et al.  Extracellular vesicle isolation and characterization: toward clinical application. , 2016, The Journal of clinical investigation.

[37]  Henrik J Johansson,et al.  Cells release subpopulations of exosomes with distinct molecular and biological properties , 2016, Scientific Reports.

[38]  C. Théry,et al.  Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes , 2016, Proceedings of the National Academy of Sciences.

[39]  R. Simpson,et al.  Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. , 2015, Methods.

[40]  J. Hurley,et al.  ESCRTs are everywhere , 2015, The EMBO journal.

[41]  Xiao‐Jing Wang,et al.  Midbody: from cellular junk to regulator of cell polarity and cell fate. , 2015, Current opinion in cell biology.

[42]  T. Verano-Braga,et al.  SuperQuant: A Data Processing Approach to Increase Quantitative Proteome Coverage. , 2015, Analytical chemistry.

[43]  J. Meldolesi,et al.  Ectosomes and exosomes: shedding the confusion between extracellular vesicles. , 2015, Trends in cell biology.

[44]  R. Minghim,et al.  InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams , 2015, BMC Bioinformatics.

[45]  C. Stratakis,et al.  PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors , 2015, Front. Cell Dev. Biol..

[46]  R. Simpson,et al.  YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment , 2015, Oncotarget.

[47]  Yu Xue,et al.  MiCroKiTS 4.0: a database of midbody, centrosome, kinetochore, telomere and spindle , 2014, Nucleic Acids Res..

[48]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[49]  Shirley L. Campbell,et al.  ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion , 2014, Molecular biology of the cell.

[50]  Weijun Luo,et al.  Pathview: an R/Bioconductor package for pathway-based data integration and visualization , 2013, Bioinform..

[51]  Hong-Jian Zhu,et al.  Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components , 2013, Proteomics.

[52]  S. Kaliyaperumal,et al.  Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities. , 2013, Mutation research.

[53]  S. Mathivanan,et al.  Two Distinct Populations of Exosomes Are Released from LIM1863 Colon Carcinoma Cell-derived Organoids* , 2012, Molecular & Cellular Proteomics.

[54]  R. Coffey,et al.  Proteomic Analysis of Exosomes from Mutant KRAS Colon Cancer Cells Identifies Intercellular Transfer of Mutant KRAS* , 2012, Molecular & Cellular Proteomics.

[55]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[56]  Stanley N Cohen,et al.  Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein , 2012, Proceedings of the National Academy of Sciences.

[57]  Richard J Simpson,et al.  Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. , 2012, Methods.

[58]  Bo Li,et al.  RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells , 2012, Oncogene.

[59]  Jared L. Johnson,et al.  Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells , 2011, Proceedings of the National Academy of Sciences.

[60]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[61]  Graca Raposo,et al.  ARF6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane Microvesicles , 2009, Current Biology.

[62]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[63]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[64]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[65]  T. Trikalinos,et al.  Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. , 2007, Evidence report/technology assessment.

[66]  Sascha Keller,et al.  Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.

[67]  J. Yates,et al.  Dissection of the Mammalian Midbody Proteome Reveals Conserved Cytokinesis Mechanisms , 2004, Science.

[68]  G. Stamp,et al.  Validation of a model of colon cancer progression , 2000, The Journal of pathology.

[69]  S. Schmid,et al.  Regulation of signal transduction by endocytosis. , 2000, Current opinion in cell biology.

[70]  R. Prekeris,et al.  Understanding post-mitotic roles of the midbody during cell differentiation and polarization. , 2017, Methods in cell biology.

[71]  Juan P Albar,et al.  The Minimal Information about a Proteomics Experiment (MIAPE) from the Proteomics Standards Initiative. , 2014, Methods in molecular biology.

[72]  Shirley L. Campbell,et al.  ARF 1 regulates the Rho / MLC pathway to control EGF-dependent breast cancer cell invasion , 2013 .

[73]  M. Glotzer,et al.  The 3Ms of central spindle assembly: microtubules, motors and MAPs , 2009, Nature Reviews Molecular Cell Biology.

[74]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[75]  JoVE Video Dataset , 2022 .